[1]SUNG H,FERLAYJ,SIEGEL RL,et al.Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality world wide for 36 cancers in 185 countries[J].CA Cancer J Clin,2021,71(3):209-249.
[2]DIXON SJ,LAMPRECHT KM.Ferroptosis:aniron-dependent form of nonapoptotic cell death[J].Cell,2012,149(5):1060-1072.
[3]SEILER A,SCHNEIDER M,FORSTER H,et al.Glutathione peroxidase 4 senses and translates oxidative stress into 12/15-lipoxygenase dependent-and AIF-mediated cell death[J].Cell Metabolism,2008,8(3):237-248.
[4]LUO M,WU L,ZHANG K,et al.miR-137 regulates ferroptosisby targeting glutamine transporter SLC1A5 in melanoma[J].Cell Death and Differentiation,2018,25(8):1457-1472.
[5]YU HT,GUO PY,XIE XZ,et al.Ferroptosis,a new form of cell death,and its relationshipswithTumourousdiseases[J].J Cell Mol Med,2017,21(4):648-657.
[6]TORII S,SHINTOKU R,KUBOTA C,et al.Anessential role forfunctional lysosomes inferroptosis of cancer cells[J].The Bio-chemical Journal,2016,473(6):769-777.
[7]RECALCATI S,GAMMELLA E,CAIRO G.Dysregulation of iron metabolism in cancer stem cells[J].Free Radical Biology & Medicine,2019,133:216-220.
[8]MIAO ZG,GUO XZ,TIAN L.The long noncoding RNA NORAD promotes the growth of gastric cancer cells by sponging miR-608[J].Gene,2019,687:116-124.
[9]LI M,QIU MT,XU YT,et al.Differentially expressed protein-coding genes and long noncoding RNA in early-stage lung cancer[J].Tumor Biol,2015,36(12):9969-9978.
[10]夏冰,江洪,王利民,等.肺癌30年临床研究进展[J].实用肿瘤杂志,2016,31(4):296-300.
XIA B,JIANG H,WANG LM,et al.Clinical research progress of lung cancer in 30 years[J].Journal of Practical Oncology,2016,31(4):296-300.
[11]KESSLER HP,POLLOCK K.Oral and maxillofacial pathology case of the month.Malignant lung cancer[J].Tex Dent J,2007,124(3):314,322-324.
[12]ASHOK S,DAMERA S,GANESH S,et al.Oral malignant lung cancer[J].Oral Maxillofac Pathol,2020,24(Suppl 1):S82-S85.
[13]RASTRELLI M,TROPEA S,ROSSI CR,et al.Lung cancer:epidemiology,risk factors,pathogenesis,diagnosis and classification[J].In Vivo,2014,28(6):1005-1011.
[14]EVANS RD,KOPF AW,LEW RA,et al.Risk factors for the development of malignant lung cancer-1:Review of case-control studies[J].J Dermatol Surg Oncol,1988,14(4):393-408.
[15]SALDANA-CABOVERDE A,KOS L.Roles of endothelin signaling in lungcancer cell development and lung cancer[J].Pigment Cell Lung Cancer Res,2010,23(2):160-170.
[16]MORT RL,JACKSONIJ,PATTON EE.The lung cancer cell lineage in development and disease[J].Development,2015,142(4):620-632.
[17]WANG WM,GREEN M,CHOI JE,et al.CD8+ T cells regulate tumour ferroptosis during cancer immunotherapy[J].Nature,2019,569(7755):270-274.
[18]PHOON YP,TANNENBAUM C,DIAZ-MONTERO CM.Immunobiology of lung cancer[J].Clin Plast Surg,2021,48(4):561-576.
[19]SPAIN L,DIEM S,LARKIN J.Management of toxicities of immune checkpoint inhibitors[J].Cancer Treat Rev,2016,44:51-60.
[20]SONG QX,PENG SX,SUN ZQ,et al.Temozolomide drives ferroptosis via a DMT1-dependent pathway in glioblastoma cells[J].Yonsei Med J,2021,62(9):843-849.
[21]WANG YN,ZHAO GY,CONDELLO S,et al.Frizzled-7 identifiesplatinum-tolerant ovarian cancer cells susceptible to ferroptosis[J].Cancer Res,2021,81(2):384-399.
[22]CADONI E,VALLETTA E,CADDEO G,et al.Competitive reactions among glutathione,cisplatin and copper-phenanthroline complexes[J].J Inorg Biochem,2017,173:126-133.
[23]WEN Y,CHEN H,ZHANG L,et al.Glycyrrhetinic acid induces oxidative/nitrative stress and drives ferroptosis through activating NADPH oxidases and iNOS,and depriving glutathione in triple-negative breast cancer cells[J].Free Radic Biol Med,2021,173:41-51.
[24]TANG DL,CHEN X,KANG R,et al.Ferroptosis:molecular mechanisms and health implications[J].Cell Res,2021,31(2):107-125.
[25]程峰,张庸,王祥,等.谷胱甘肽过氧化物酶GPX4在铁死亡中的作用与机制研究进展[J].现代肿瘤医学,2021,29(7):1254-1258.
CHENG F,ZHANG Y,WANG X,et al.Research progress on the role and mechanism of GPX4 in ferroptosis [J].Modern Oncology,2021,29(7):1254-1258.
[26]LI J,CAO F,YIN HL,et al.Ferroptosis:past,present and future[J].Cell Death Dis,2020,11(2):88.
[27]YU HT,GUO PY,XIE XZ,et al.Ferroptosis,a new form of cell death,and its relationships with tumourous diseases[J].J Cell Mol Med,2017,21(4):648-657.
[28]SATO M,KUSUMI R,HAMASHIMA S,et al.The ferroptosis inducer erastin irreversibly inhibits system xc- and synergizes with cisplatin to increase cisplatin's cytotoxicity in cancer cells[J].Sci Rep,2018,8(1):968.
[29]LU B,CHEN XB,YING MD,et al.The role of ferroptosis in cancer development and treatment response[J].Front Pharmacol,2018,8:992.
[30]GIBB EA,BROWN CJ,LAM WL.The functional role of long non-coding RNA in human carcinomas[J].Mol Cancer,2011,10:38.
[31]SPIZZOR,ALMEIDA MI,COLOMBATTI A,et al.Long non-coding RNAs and cancer:a new frontier of translational research[J].Oncogene,2012,31(43):4577-4587.